METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics Recent advances in spatial transcriptomics (ST) have improved insights into the tumor [...]
Structural Basis for Self-Discrimination by Neoantigen-Specific TCRs This study highlights the RNA sequencing and whole exome sequencing data associated with the investigation of a [...]
Patient advocates bring essential perspectives to cancer research and are involved in several consortia associated with the MC2 Center. To support their efforts, as [...]
Creating Diverse, Equitable, and Inclusive Teams Dr. LaKaija Johnson, Principal Scientist, Team Science October 16, 2024, 11:00 AM - Noon PT / 2:00 - [...]
This study aims to compare the epigenomes of different patient-derived models of colorectal cancer (PDO (Patient-Derived Organoid), PDX (Patient-Derived Xenograft), and PDOX (Patient-Derived Orthotopic [...]
Cut&Tag sequencing data from melanoma cells revealed that BAHCC1, a gene associated with Super-Enhancers (SE) and critical for cancer growth, is highly active compared [...]
Updated and expanded resource management documentation has been added to the CCKP! This update adds several new sections: how to store your data in a [...]
September 23 - 27, 2024 in the Washington D.C Area The 2024 From Atlas to Practice Innovation Lab will bring together spatial biologists with practicing [...]
Guest Author: Ashenafi Bulle, Ph.D., Washington University School of Medicine in St. Louis In this work, we shed light on the significance of drug combinations [...]
Setting Boundaries at Work - Workshop with Dr. Betsy Rolland Monday, May 11, 2024 at 11:00 AM PT / 2:00 PM ET We will explore [...]
